Loading market data...
Tue, 20 Oct 2026
03:30:39 pm
Tue, 20 Oct 2026
03:30:39 pm
Rudransh Sangwan
Published at: October 16, 2026, 10:31 AM
Synopsis
ICICI Prudential Life share price closed at ₹445 on October 16, 2026, down 0.90%. Check its 52-week high and low, stock returns, quarterly profit and analyst ratings.
ICICI Prudential Life Insurance shares closed 0.90% lower at ₹445 on October 16, 2026, on the NSE. The stock traded between an intraday high of ₹451.30 and a low of ₹435.20.
The stock’s 52-week high stands at ₹706.80, while its 52-week low is ₹435.20. Shares have declined 24.19% over the past year and 12.55% in the last three months.
| Metric | Details |
|---|---|
| Closing price | ₹445.00 |
| Daily change | -0.90% |
| Intraday high | ₹451.30 |
| Intraday low | ₹435.20 |
| 52-week high | ₹706.80 |
| 52-week low | ₹435.20 |
| Market capitalisation | ₹64,705 crore |
| P/E ratio | 36.44 |
| P/B ratio | 4.78 |
| Dividend yield | 0.37% |
| Volume traded | 39.15 lakh shares |
| Period | Return |
|---|---|
| 1 day | -0.90% |
| 1 week | -3.38% |
| 1 month | -5.32% |
| 3 months | -12.55% |
| 1 year | -24.19% |
| 3 years | -16.20% |
| 5 years | -31.74% |
The figures show that the stock has declined across all the listed periods, including the one-year and five-year timeframes.
ICICI Prudential Life reported profit after tax (PAT) of ₹623.91 crore for the quarter ended March 2026, compared with ₹387.15 crore in December 2025. This represented a sequential increase of approximately 61.15%.
Total income stood at ₹4,221.02 crore in March 2026, compared with ₹22,591.14 crore in the December 2025 quarter. The reported quarter-on-quarter decline in total income was 81.32%, according to the supplied consolidated financial data. The figures may reflect changes in insurance accounting and business flows, so total income should not be interpreted in isolation.
The average recommendation from 33 analysts is Buy, according to the supplied ET Markets data. The ratings include 14 Strong Buy, 16 Buy and three Hold recommendations.
The displayed analyst target prices include ₹650 from JM Financial and ₹780 from Motilal Oswal Financial Services, both dated in 2025. These are historical recommendations and should not be treated as current price targets.
As of June 2026, promoters held 72.73% of the company. Foreign institutional investors held 10.22%, while domestic institutional investors held 11.81%. Mutual fund ownership stood at 10.39%.
Market data is based on the supplied ET Markets figures for October 16, 2026. This article is for informational purposes only and is not investment advice.
ICICI Prudential Life Insurance shares closed at ₹445 on the NSE on October 16, 2026, down 0.90% for the day.
The stock's 52-week high is ₹706.80, while its 52-week low is ₹435.20, according to the supplied data.
The stock declined 24.19% over one year and 31.74% over five years, based on the supplied figures.
The company's reported market capitalisation was approximately ₹64,705 crore.
The reported price-to-earnings (P/E) ratio was 36.44, while its price-to-book (P/B) ratio was 4.78.
The company reported profit after tax of ₹623.91 crore for the quarter ended March 2026, compared with ₹387.15 crore in the December 2025 quarter, according to the supplied data.
The reported total income was ₹4,221.02 crore in March 2026, compared with ₹22,591.14 crore in December 2025. These figures should be interpreted in the context of insurance accounting and the company's reported financial statements.
Of the 33 analysts cited, 14 rated the stock Strong Buy, 16 rated it Buy and three rated it Hold. The average recommendation was Buy. Analyst ratings can change and do not guarantee future returns.
The supplied data lists historical target prices of ₹650 from JM Financial and ₹780 from Motilal Oswal Financial Services, both dated in 2025. These should not be treated as current analyst targets.
As of June 2026, promoters held 72.73%, foreign institutional investors held 10.22%, domestic institutional investors held 11.81% and mutual funds held 10.39%, according to the supplied data.
That depends on its valuation, premium growth, profitability, insurance business performance and an investor's risk tolerance. Investors should review the latest financial results and current analyst research rather than relying only on historical returns or older price targets.
Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.
L&T has begun preliminary work on the New Tashkent International Airport project after receiving a limited notice to proceed.
DLF share price has 41% upside, according to HSBC’s target. Compare Jefferies, CLSA and other broker views on sales, cash flow and valuations.
Divi's Laboratories shares rose 1.01% to Rs 9,242.50 after a positive EU opinion on Eli Lilly's weight loss drug Foundayo. See the growth outlook.
Awfis revenue target exceeds Rs 1,800 crore for FY27, with flexible workspace demand supporting growth. Expansion and execution remain key to watch.
L&T has won a contract worth over Rs 15,000 crore. The client, project scope and execution timeline remain undisclosed, leaving its revenue impact...
